Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OMALIZUMAB Cause Multiple fractures? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Multiple fractures have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.0% of all adverse event reports for OMALIZUMAB.

28
Reports of Multiple fractures with OMALIZUMAB
0.0%
of all OMALIZUMAB reports
0
Deaths
17
Hospitalizations

How Dangerous Is Multiple fractures From OMALIZUMAB?

Of the 28 reports, 17 (60.7%) required hospitalization, and 8 (28.6%) were considered life-threatening.

Is Multiple fractures Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does OMALIZUMAB Cause?

No adverse event (9,736) Asthma (9,354) Urticaria (9,231) Off label use (9,199) Dyspnoea (8,323) Drug ineffective (6,747) Cough (5,926) Pruritus (5,224) Fatigue (5,053) Malaise (4,820)

What Other Drugs Cause Multiple fractures?

EMTRICITABINE\TENOFOVIR DISOPROXIL (8,088) TENOFOVIR DISOPROXIL (6,793) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,102) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,942) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (1,489) DENOSUMAB (415) NEXIUM (346) ADALIMUMAB (305) ETANERCEPT (251) ABATACEPT (217)

Which OMALIZUMAB Alternatives Have Lower Multiple fractures Risk?

OMALIZUMAB vs OMAVELOXOLONE OMALIZUMAB vs OMBITASVIR OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS

Related Pages

OMALIZUMAB Full Profile All Multiple fractures Reports All Drugs Causing Multiple fractures OMALIZUMAB Demographics